Enanta Pharmaceuticals | 8-K: Current report
Enanta Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Director Vance Terry
Enanta Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Director Russell Lesley
Enanta Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Director Peterson Kristine
Enanta Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Director Hata Yujiro S
Enanta Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Director FOLETTA MARK G
Enanta Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Director CARTER BRUCE L A
Enanta Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Officer Gardiner Nathaniel S.
Enanta Pharmaceuticals | SCHEDULE 13G: Others
Enanta Pharmaceuticals | UPLOAD: Others
Enanta Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Officer Luu Brendan
Enanta Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Officer Kieffer Tara Lynn
Enanta Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Officer Gardiner Nathaniel S.
Enanta Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Officer Rottinghaus Scott T.
Enanta Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Officer Or Yat Sun
Enanta Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Officer MELLETT PAUL J
Enanta Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Officer Luly Jay R.
Enanta Pharmaceuticals | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Armistice Capital, LLC(9.80%),Steven Boyd(9.80%)
Enanta Pharmaceuticals | CORRESP: CORRESP
Enanta Pharmaceuticals | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-The Vanguard Group(8.52%)
No Data